Drug Profile
OralTAC
Latest Information Update: 22 Sep 2023
Price :
$50
*
At a glance
- Originator Kiromic
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Acute myeloid leukaemia; Gastrointestinal cancer; Ovarian cancer
Most Recent Events
- 15 Sep 2023 Discontinued - Preclinical for Acute myeloid leukaemia in USA (PO) before September 2023
- 15 Sep 2023 Discontinued - Preclinical for Gastrointestinal cancer in USA (PO) before September 2023
- 15 Sep 2023 Discontinued - Preclinical for Ovarian cancer in USA (PO) before September 2023